- Home
- HLI vs COO Comparison
HLI vs COO Comparison
Compare HLI & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLI
- COO
- Stock Information
- Founded
- HLI 1972
- COO 1980
- Country
- HLI United States
- COO United States
- Employees
- HLI N/A
- COO N/A
- Industry
- HLI Investment Managers
- COO Ophthalmic Goods
- Sector
- HLI Finance
- COO Health Care
- Exchange
- HLI Nasdaq
- COO Nasdaq
- Market Cap
- HLI 14.4B
- COO 14.2B
- IPO Year
- HLI 2015
- COO N/A
- Fundamental
- Price
- HLI $182.16
- COO $71.64
- Analyst Decision
- HLI Hold
- COO Buy
- Analyst Count
- HLI 9
- COO 11
- Target Price
- HLI $205.38
- COO $79.27
- AVG Volume (30 Days)
- HLI 560.8K
- COO 2.4M
- Earning Date
- HLI 10-30-2025
- COO 12-04-2025
- Dividend Yield
- HLI 1.32%
- COO N/A
- EPS Growth
- HLI 26.59
- COO 13.33
- EPS
- HLI 6.19
- COO 2.04
- Revenue
- HLI $2,565,361,000.00
- COO $4,045,700,000.00
- Revenue This Year
- HLI $14.85
- COO $6.02
- Revenue Next Year
- HLI $13.67
- COO $5.81
- P/E Ratio
- HLI $29.32
- COO $34.68
- Revenue Growth
- HLI 21.01
- COO 6.35
- 52 Week Low
- HLI $137.99
- COO $61.78
- 52 Week High
- HLI $211.78
- COO $106.63
- Technical
- Relative Strength Index (RSI)
- HLI 36.83
- COO 55.09
- Support Level
- HLI $177.27
- COO $67.20
- Resistance Level
- HLI $184.91
- COO $70.12
- Average True Range (ATR)
- HLI 5.16
- COO 1.51
- MACD
- HLI -1.00
- COO -0.15
- Stochastic Oscillator
- HLI 20.13
- COO 57.67
About HLI Houlihan Lokey Inc.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.